Babylon Holdings Limited R&D Expenses

R&D Expenses of BBLN for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.

Highlights and Quick Summary

  • R&D Expenses for the quarter ending September 30, 2022 was $16.2 Million (a -13.01% decrease compared to previous quarter)
  • Year-over-year quarterly R&D Expenses increased by 47.64%
  • Annual R&D Expenses for 2021 was $47.5 Million (a -13.12% decrease from previous year)
  • Annual R&D Expenses for 2020 was $54.7 Million (a 6.85% increase from previous year)
  • Twelve month R&D Expenses ending September 30, 2022 was $55.9 Million (a -5.26% decrease compared to previous quarter)
  • Twelve month trailing R&D Expenses increased by 17.68% year-over-year
Trailing R&D Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$55.9 Million $59 Million $47.2 Million $47.5 Million
Visit stockrow.com/BBLN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of Babylon Holdings Limited

Most recent R&D Expensesof BBLN including historical data for past 10 years.

Interactive Chart of R&D Expenses of Babylon Holdings Limited

Babylon Holdings Limited R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $16.23 $18.66 $10.06 –
2021 $10.99 $19.34 $6.81 $10.39 $47.53
2020 – – – – $54.71
2019 – – – – $51.21

Business Profile of Babylon Holdings Limited

Sector: Healthcare
Industry: Health Information Services
© stockrow.com